Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

HUMAN PHEROMONE SCIENCES INC (EROX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-10Dec-31-09Dec-31-08Dec-31-07
   10-K10-K10-K10-K
Revenues:  
    License revenues (worldwide)  0.50.60.60.5
    Net Sales by Markets  0.30.30.40.8
    U.S Markets    0.3 
    International Markets    0.1 
Total revenues  0.80.91.01.3
            Revenue growth   [+]-8.9%-10.8%-23.2% 
Cost of goods sold  0.10.20.30.4
Gross profit  0.70.70.70.9
            Gross margin  84.1%78.0%67.5%70.9%
Selling, general and administrative  0.80.90.90.9
Research and development  0.00.10.00.0
EBITDA   [+]-0.1-0.3-0.3-0.1
            EBITDA margin  -11.7%-32.2%-26.7%-5.7%
Depreciation and amortization  0.00.00.00.0
EBIT   [+]-0.1-0.3-0.3-0.1
            EBIT margin  -11.8%-32.3%-26.8%-5.9%
Interest income   0.00.00.1
Pre-tax income  -0.1-0.3-0.20.0
Income taxes  0.00.00.00.0
Net income  -0.1-0.3-0.20.0
            Net margin  -12.0%-32.1%-24.1%-1.2%
   
Basic EPS   [+]($0.02)($0.07)($0.06)$0.00
Diluted EPS   [+]($0.02)($0.07)($0.06)$0.00
   
Shares outstanding (basic)   [+]4.94.14.04.2
Shares outstanding (diluted)   [+]4.94.14.04.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy